RETN and metabolic disease: Experimental results from cardiomyocytes isolated from diabetic rat hearts suggest that Ca2+ dyshomeostasis and altered Ca2+/ATPase (Serca2) activity are key mechanisms driving the upregulation of resistin expression in this metabolic disorder [56].